Coronavirus Disease 2019 (COVID-19)
FDA is working with U.S. government partners, including CDC, and international partners to address the pandemic.
Topic Paragraphs
Featured Topics
Recent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Dec 06
Cranberry Sweets & More Issues Allergy Alert On Undeclared Peanuts In “Mint Meltaways”
Food & Beverages
Dec 06
Northern Food I/E Recalls “Sweetened Jujube” Due to Undeclared Sulfites
Food & Beverages
Dec 06
LIDL Voluntarily Recalls 8.4 Oz Favorina Branded Advent Calendar (Premium Chocolate with a Creamy Filling) Due to Potential Salmonella Contamination
Food & Beverages
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
FDA’s Cybersecurity Modernization Action Plan
CMAP will leverage Artificial Intelligence and Machine Learning technologies to enhance cyber detection and response capabilities.
Focusing on Prevention to Safeguard Infant Formula
FDA is working with infant formula manufacturers to maximize production and taking steps to assure the public that infant formula is and will remain safe.
FDA Continues to Advance Medicines for Children
Increasing the availability of safe and effective medicines for children is a key priority for the U.S. Food and Drug Administration.
Recently Published Guidances
Dec 09
Content of Human Factors Information in Medical Device Marketing Submissions
Medical Devices
Dec 09
Voluntary Malfunction Summary Reporting (VMSR) Program for Manufacturers
Biologics, Medical Devices
Dec 07
Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria
Biologics